Estrogen receptor and breast cancer: understanding the link

The estrogen receptor (ER) is a critical protein involved in regulating various biological processes, particularly in breast tissue. It plays a vital role in cell proliferation and differentiation. Abnormal ER signaling can lead to breast cancer development and progression.

At AnyGenes, we provide innovative SignArrays^® designed for high-throughput analysis of estrogen receptor and breast cancer. Our customizable arrays allow researchers to investigate the mechanisms underlying ER+ breast cancer, facilitating advancements in personalized medicine and therapeutic strategies.

Discover our advanced qPCR arrays for Estrogen Receptor and Breast Cancer research.

Model of estrogen signaling pathways in cancer.

The role of estrogen receptor in breast cancer

Estrogen receptors are proteins found inside and on the surface of breast cells. When estrogen binds to these receptors, it activates signaling pathways that promote cell growth and proliferation. In ER⁺ breast cancer, the presence of estrogen receptors leads to uncontrolled cell division, contributing to tumor growth.

Types of estrogen receptors

There are two main types of estrogen receptors:

ERα (Estrogen Receptor Alpha): primarily involved in breast cancer development. Its activation leads to the transcriptionof genes that stimulate cell growth.
ERβ (Estrogen Receptor Beta): generally thought to have a protective role against breast cancer, ERβ’s function is still under investigation.

Estrogen receptor-positive breast cancer

ER⁺ breast cancers are often more responsive to hormone therapies, making early detection and accurate diagnosis essential. Common subtypes of ER⁺ breast cancer include:

Luminal 1: typically low grade, slower growing, and often more responsive to hormone therapy.
Luminal B: higher grade, may be more aggressive, and also express HER2.
ER-positive (ER⁺): these tumors depend on estrogen for growth and are sensitive to endocrine therapies.
ER-positive (ER^–): these tumors do not express estrogen receptors and typically require different treatment approaches.

Diagnosis and treatment

Diagnosing ER⁺ breast cancer typically involves:

Immunohistochemistry: a test that detects the presence of estrogen receptors in tissue samples.
Gene expression profiling: assessing the activity of specific genes to determine the cancer subtype.

Treatment options for ER⁺ breast cancer often include:

Hormonal therapy: medications such as tamoxifen and aromatase inhibitors block estrogen’s effects, slowing or stopping the growth of cancer cells.
Targeted therapy: drugs specifically target HER2 receptors may be used in conjunction with hormonal therapies. Emerging therapies: New agents targeting ER signaling are being developed to overcome treatment resistance caused by mutations in the ER gene.
Resistance mechanism

Analyze your pathway data with AnyGenes® software

Scientific data is only as powerful as the analysis behind it.

AnyGenes® provides a dedicated data analysis tool specifically developed for SignArrays® pathway panels.

What does it allow you to do?

Automated ΔCq calculation
Normalization with selected housekeeping genes
Comparison of up to 10 experimental conditions
Generation of descriptive statistics
Publication-ready graphs
Exportable tables for manuscripts and presentations

Developed on Excel (compatible with 2007+), the software is user-friendly and requires no advanced bioinformatics skills.

Customize your own signaling pathways (SignArrays®) with the factors of your choice!
Simply download and complete our Personalized SignArrays® information file and send it at [email protected] to initiate your project.

Estrogen receptor & breast cancer biomarker list

You can check the biomarker list included in this pathway, see below:

Species : Homo sapiens (human)

Human Estrogen Receptor & Breast Cancer

Signaling Pathways	Product ref	Informations
Estrogen Receptor & Breast Cancer	ERBC1H1	Download biomarker list

Species : Mus musculus (mouse)

Mouse Estrogen Receptor & Breast Cancer

Signaling Pathways	Product ref	Informations
Estrogen Receptor & Breast Cancer	ERBC1M1	Download biomarker list

Species : Rattus norvegicus (rat)

Rat Estrogen Receptor & Breast Cancer

Signaling Pathways	Product ref	Informations
Estrogen Receptor & Breast Cancer	*******	Biomarker list in progress.

Species : Sus Scrofa (Pig)

Pig Estrogen Receptor & Breast Cancer

Signaling Pathways	Product ref	Informations
Estrogen Receptor & Breast Cancer	*******	Biomarker list in progress.

Looking for more answers? Visit our Help & FAQ section to find detailed informations about our products, services, and technical support.

Bibliography

1. Miziak P, et al. Estrogen Receptor Signaling in Breast Cancer. Cancers (Basel). (2023)23;15(19):4689.

2. Clusan L, et al. A Basic Review on Estrogen Receptor Signaling Pathways in Breast Cancer. Int J Mol Sci. 2023 Apr 6;24(7):6834.

3. SM, Mittendorf EA, Guerriero JL. The Immunology of Hormone Receptor Positive Breast Cancer. Front Immunol. (2021)11;12:674192.

4. Hsu LH, et al. G-Protein Coupled Estrogen Receptor in Breast Cancer. Int J Mol Sci. (2019)14;20(2):306.

Need pricing information or distributor details?
For quotations, product information, or project discussions, please contact our team at [email protected].